Maine § 24-A §2837-F Off-label use of prescription drugs for cancer

Maine Statutes

§ 24-A §2837-F — Off-label use of prescription drugs for cancer

Maine § 24-A §2837-F

Title 24-AMAINE INSURANCE CODE

Ch. 35GROUP AND BLANKET HEALTH INSURANCE

This text of Maine § 24-A §2837-F (Off-label use of prescription drugs for cancer) is published on Counsel Stack Legal Research, covering Maine primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Me. Rev. Stat. tit. 24-A, § 24-A §2837-F (2026).

Text

1.Definitions. As used in this section, unless the context otherwise indicates, the following terms have the following meanings.

2.Required coverage for off-label use. All group insurance policies and contracts that provide coverage for prescription drugs must provide coverage for off-label use in accordance with the following.

3.Application. The requirements of this section apply to all policies, contracts and certificates executed, delivered, issued for delivery, continued or renewed in this State on or after January 1, 1999. For purposes of this section, all contracts are deemed to be renewed no later than the next yearly anniversary of the contract date.

Free access — add to your briefcase to read the full text and ask questions with AI

1.
Definitions.
As used in this section, unless the context otherwise indicates, the following terms have the following meanings.
2.
Required coverage for off-label use.
All group insurance policies and contracts that provide coverage for prescription drugs must provide coverage for off-label use in accordance with the following.
3.
Application.
The requirements of this section apply to all policies, contracts and certificates executed, delivered, issued for delivery, continued or renewed in this State on or after January 1, 1999. For purposes of this section, all contracts are deemed to be renewed no later than the next yearly anniversary of the contract date.